Viread

Indicated For

HIV, HBV

About This Medication

# Gilead Advancing Access Patient Assistance Program Patient Guide: How to Get Viread (tenofovir disoproxil fumarate) at Low or No Cost Viread (tenofovir disoproxil fumarate) is a prescription medication used to treat HIV infection in adults and children, and chronic hepatitis B in adults with compensated liver disease. The **Gilead Advancing Access Patient Assistance Program (PAP/MAP)** helps eligible uninsured patients get Viread free of charge if they meet income and other requirements. ## About Viread **Viread**, or tenofovir disoproxil fumarate, is an antiviral medicine that belongs to a class of drugs called nucleotide reverse transcriptase inhibitors (NRTIs). It works by blocking an enzyme HIV needs to multiply, helping to reduce the amount of virus in your body and keep your immune system strong. For hepatitis B, it stops the virus from multiplying in the liver. It's typically taken once daily as an oral tablet, often combined with other antiretrovirals for HIV. Always take Viread exactly as prescribed by your doctor. Common side effects may include nausea, diarrhea, headache, or kidney issues—discuss any concerns with your healthcare provider. This program focuses on access for those who can't afford it, but it's not a substitute for medical advice. ## Who Qualifies for the Program? The Gilead Advancing Access PAP/MAP is designed for **uninsured** U.S. residents (including Puerto Rico and U.S. Territories) who need help affording Gilead medications like Viread. Key qualifications include: - Being uninsured or having limited insurance coverage. - Residing in the U.S., Puerto Rico, or U.S. Territories (proof may be required). - Meeting income limits based on Federal Poverty Level (FPL). - Having a valid prescription from a licensed healthcare provider. You must notify the program if your insurance status changes. Enrollment lasts up to **12 months**, with ongoing eligibility checks to ensure you still qualify. ## Income Eligibility Breakdown Eligibility is primarily based on household income at or below **500% of the Federal Poverty Level (FPL)** for uninsured patients. Exact dollar thresholds vary by household size and change annually with FPL updates. Use the table below as a general guide (based on 2026 FPL estimates; confirm current figures by calling the program). | Household Size | Annual Income Limit (≤500% FPL) | |----------------|---------------------------------| | 1 (Individual) | $75,300 | | 2 (Couple) | $102,000 | | 3 | $128,600 | | 4 | $155,300 | | +1 per person | +$26,700 | **Notes**: Income includes all household earnings. Provide proof like tax returns, W-2s, or pay stubs if requested. Program reserves the right to verify and may adjust eligibility. ## Insurance Requirements This program is for **uninsured patients** or those with limited coverage. You must: - Confirm you have no or minimal insurance. - Notify Advancing Access immediately if you gain insurance, as this may end your eligibility. - Not be enrolled in government programs that fully cover Viread (though some limited coverage may be okay—call to check). Medicare patients may have separate co-pay options via Gilead's Co-pay Savings Program, but PAP/MAP is mainly for the uninsured. ## Step-by-Step Application Process Applying is straightforward—start by phone, as it's the primary method: 1. **Get Your Prescription**: Ask your doctor for a prescription for Viread and have them complete the provider section of the enrollment form. 2. **Contact Advancing Access**: Call **(800) 226-2056** (Monday–Friday, 9 AM–8 PM ET). A program specialist will guide you. Mention English is not your primary language if needed for translation. 3. **Complete Enrollment**: Provide your info over the phone or download/fax the form (available at GileadAdvancingAccess.com). Key fields: personal details, income, insurance status, prescription, signatures from you and your doctor. 4. **Submit Documents**: Fax to the number provided (e.g., 1-800-216-6857). May need ID, income proof (tax return, pay stubs), proof of residency. 5. **Wait for Review**: Expect a call within 2 business days to discuss next steps. 6. **Approval Notification**: If approved, medication ships free to your home or doctor's office. Your doctor can also enroll via the HCP portal or fax. ## Timeline and Delivery - **Processing Time**: Forms reviewed in about **2 business days**; online enrollment may give immediate decisions. - **Delivery**: Free shipping to patient or physician's office once approved. - **Enrollment Duration**: Up to 12 months, with periodic checks. Reauthorization needed annually or if circumstances change. Call if urgent—specialists can expedite. ## Alternatives if Denied If ineligible: - **Co-pay Savings Program**: For commercially insured patients to reduce out-of-pocket costs. - **AIDS Drug Assistance Program (ADAP)**: State programs for HIV meds—apply via your state health department. - **Benefits Investigation**: Program can check your insurance coverage or prior authorizations. - **Other Resources**: NeedyMeds.org, RxAssist.org, or patient advocacy groups like PAN Foundation. - **Appeal**: Call to discuss denial reasons and resubmit updated info. No biosimilar alternatives for Viread are currently available through this program. ## Important Disclaimer This guide is for informational purposes only and based on program details as of March 2026. Gilead Sciences can change, modify, or end the program anytime without notice. Eligibility isn't guaranteed—always verify with Advancing Access at (800) 226-2056. This is not medical advice; consult your doctor for treatment decisions. Income tables are estimates; use official FPL calculators for precision. By enrolling, you authorize sharing of health, insurance, and financial info for eligibility verification.

Program information last verified: March 30, 2026